688428.SHG InnoCare Pharma Ltd. A

Healthcare Biotechnology Shanghai Stock Exchange
168.38 CNY
Close of Nov 4, 2026
19.36 35.00
Market cap
CNY 46.0B
P/E
44.2x
P/B
5.12x
ROE
8.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 688428.SHG undervalued?

Graham number

The Graham number of InnoCare Pharma Ltd. A cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

InnoCare Pharma Ltd. A fundamental analysis

No fundamental analysis for InnoCare Pharma Ltd. A yet.

InnoCare Pharma Ltd. A stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About InnoCare Pharma Ltd. A

InnoCare Pharma Limited, a biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China. The company develops Orelabrutinib, an BTK inhibitor to treat patients with relapsed and/or refractory (r/r) chronic lymphocytic leukemia, r/r mantle cell lymphoma, r/r Waldenstrom's macroglobulinemia, r/r marginal zone lymphoma, r/r diffuse large B-cell lymphoma (DLBCL)- MCD, r/r central nervous sys…

Full company profile